ActivX Biosciences, Inc.
La Jolla, CA 92037 (Map) Phone: 858-558-5558
Fax: 858-587-4878
http://www.activx.com
Overview
ActivX Biosciences figures that the more you know about protein kinases, the easier it will be to inhibit them. That's the basis of its main product: a platform to profile protein kinases -- enzymes that regulate cells' signaling pathways. Its KiNativ platform has been launched for use by pharmaceutical and biotechnology companies as they develop the kinase inhibitors expected to make drug breakthroughs. The company also has its own pipeline of drug candidates in development, including one in trials for the treatment of Type-2 diabetes. Japanese drugmaker Kyorin Pharmaceutical, with whom ActivX had collaborated since 2002, bought the company in 2005 for $21 million.
Key Numbers from Hoover's UK
Key financials for ActivX Biosciences, Inc.
| Company Type | Subsidiary of Kyorin Co. |
|---|---|
| Fiscal Year-End | March |
Key People from Hoover's UK
Key people and executives for ActivX Biosciences, Inc.
| Chairman and President | John W. Kozarich (Subscribers see complete biographies -- view sample)
|
|---|---|
| VP, CFO and Director | Yoh Ito |
| Director Chemistry and Business Development | Anna Katrin Szardenings |
Top Competitors from Hoover's UK
Top competitors of ActivX Biosciences, Inc.
There are 6 competitors for ActivX; see more.
